<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>ir-10054-5918</identifier><datestamp>2011-12-27T05:39:03Z</datestamp><dc:title>2,3-Disubstituted-1,4-naphthoquinones, 12H-benzo[b]phenothiazine-6, 11-diones and related compounds: Synthesis and Biological evaluation as potential antiproliferative and antifungal agents</dc:title><dc:creator>TANDON, VK</dc:creator><dc:creator>MAURYA, HK</dc:creator><dc:creator>TRIPATHI, A</dc:creator><dc:creator>SHIVAKESHAVA, GB</dc:creator><dc:creator>SHUKLA, PK</dc:creator><dc:creator>SRIVASTAVA, P</dc:creator><dc:creator>PANDA, D</dc:creator><dc:subject>1,4-naphthoquinone derivatives</dc:subject><dc:subject>naphthoquinone derivatives</dc:subject><dc:subject>antiallergic activities</dc:subject><dc:subject>antibacterial agents</dc:subject><dc:subject>cell-proliferation</dc:subject><dc:subject>anticancer agents</dc:subject><dc:subject>cytotoxicity</dc:subject><dc:subject>antiplatelet</dc:subject><dc:subject>inhibitors</dc:subject><dc:subject>mitosis</dc:subject><dc:subject>antiproliferative</dc:subject><dc:subject>1,4-naphthoquinone derivatives</dc:subject><dc:subject>cytotoxic</dc:subject><dc:subject>human cervical cancer (hela) cells</dc:subject><dc:subject>antifungal</dc:subject><dc:description>A series of 2-chloro-3-arylsulfanyl-[1,4]naphthoquinones (2), 2,3-bis-arylsulfanyl-[1,4]naphthoquinones (3) and 12H-benzo[b]phenothiazine-6,11-diones and their analogs 6-8 were synthesized and evaluated for their antiproliferative activity against human cervical cancer (HeLa) cells. Compounds 3a and 3b were found to possess most potent antiproliferative and cell killing ability. Compounds 1-8 were also evaluated for antifungal activities. The structure-activity relationship of these compounds was studied and the results show that compound 2a (MIC(50) = 1.56 mu g/mL) exhibited in vitro potent antifungal activity compared to the clinically useful antifungal. drug Fluconazole (MIC(50) = 2.0 mu g/mL) against Sporothrix. schenckii. Compound 2a (MIC(50) = 1.56 mu g/mL) also exhibited same antifungal activity compared to clinically useful drug Amphotericin-B (MIC(50) = 1.56 mu g/mL) against Trichophyton. mentagraphytes. (C) 2008 Elsevier Masson SAS. .</dc:description><dc:publisher>ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER</dc:publisher><dc:date>2011-07-21T16:11:00Z</dc:date><dc:date>2011-12-26T12:52:04Z</dc:date><dc:date>2011-12-27T05:39:03Z</dc:date><dc:date>2011-07-21T16:11:00Z</dc:date><dc:date>2011-12-26T12:52:04Z</dc:date><dc:date>2011-12-27T05:39:03Z</dc:date><dc:date>2009</dc:date><dc:type>Article</dc:type><dc:identifier>EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 44(3), 1086-1092</dc:identifier><dc:identifier>0223-5234</dc:identifier><dc:identifier>http://dx.doi.org/10.1016/j.ejmech.2008.06.025</dc:identifier><dc:identifier>http://dspace.library.iitb.ac.in/xmlui/handle/10054/5918</dc:identifier><dc:identifier>http://hdl.handle.net/10054/5918</dc:identifier><dc:language>en</dc:language></oai_dc:dc>